+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Complex Regional Pain Syndrome Drug"

Complex Regional Pain Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Complex Regional Pain Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Complex Regional Pain Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Complex Regional Pain Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 65 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Complex Regional Pain Syndrome (CRPS) is a chronic pain disorder that affects the peripheral and central nervous systems. It is characterized by severe, burning pain, swelling, and changes in skin color and temperature. Treatment for CRPS typically involves a combination of medications, physical therapy, and psychological therapy. Drugs used to treat CRPS include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anticonvulsants, antidepressants, and topical anesthetics. These drugs are used to reduce pain, inflammation, and muscle spasms. In some cases, nerve blocks and injections may be used to provide relief. The CRPS drug market is a subset of the larger Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and epilepsy. Some companies in the CRPS drug market include Pfizer, Novartis, GlaxoSmithKline, Merck, and Johnson & Johnson. Show Less Read more